PRF1 and acute myeloid leukemia: We speculate that in AML patients, despite reduced Th1-type cytokine production, MAIT cells may exert anti-tumor effects primarily through granzyme B and perforin-mediated degranulation and cytokine activation, as indicated by the increased secretion of Th17-type cytokines and cytotoxic molecules.